Introduction Shandong Qilu Cell Therapy Engineering Technology Co., Ltd., founded in 2011 and part of the Shandong YinFeng Biological Group, specializes in cellular technology development, clinical research, and cell therapy product registration. With a focus on stem and immune cell technologies, the company engages in clinical research, translational services, CAR-T cell products, adult cell storage, and novel cell-derived products, providing personalized treatment solutions. It is one of the few high-tech enterprises in the cellular technology sector encompassing the entire industry chain from upstream to downstream R&D. |